MLC tracking for lung SABR is feasible, efficient and delivers high-precision target dose and lower normal tissue dose

Autor: Doan Trang Nguyen, Alexander Podreka, Kathryn Szymura, Benjamin Harris, Vincent Caillet, Thomas Eade, Ricky O'Brien, Dasantha Jayamanne, Georgios I. Angelis, Nicholas Hardcastle, Per Rugaard Poulsen, Meegan Shepherd, Jeremy T. Booth, Carol Haddad, Paul J. Keall, Adam Briggs

Publikováno v: Booth, J, Caillet, V, Briggs, A, Hardcastle, N, Angelis, G, Jayamanne, D, Shepherd, M, Podreka, A, Szymura, K, Nguyen, D T, Poulsen, P, O'Brien, R, Harris, B, Haddad, C, Eade, T & Keall, P 2021, ' MLC tracking for lung SABR is feasible, efficient and delivers high-precision target dose and lower normal tissue dose ', Radiotherapy and Oncology, vol. 155, pp. 131-137 . https://doi.org/10.1016/j.radonc.2020.10.036

Background and purposeThe purpose of this work is to present the clinical experience from the first-in-human trial of real-time tumor targeting via MLC tracking for stereotactic ablative body radiotherapy (SABR) of lung lesions.Methods and materialsS

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aefa603a2a3e05b7c52db3e61c93b819
https://doi.org/10.1016/j.radonc.2020.10.036

Interim Results of a Prospective Prostate-Specific Membrane Antigen-Directed Focal Stereotactic Reirradiation Trial for Locally Recurrent Prostate Cancer

Autor: Andrew Kneebone, Kathryn Szymura, Carol Kwong, Julia Hunter, Sarah Bergamin, George Hruby, Andrew Le, Thomas Eade, Jeremy T. Booth, Chris Brown, Geoffrey Schembri, Edward C. Hsiao

Publikováno v: International journal of radiation oncology, biology, physics. 108(5)

Purpose To report the feasibility, toxicity, and preliminary outcomes (metabolic and biochemical) of 68Ga-prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT)–directed focal prostate reirradiation usin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef0ada48b1a67ae3b6bd69b7b1acd55c
https://pubmed.ncbi.nlm.nih.gov/32659332

OC-0298 MLC tracking for lung cancer SABR is clinically feasible: results of first-in-human clinical trial

Autor: O. Ricky, Vincent Caillet, Dasantha Jayamanne, Kathryn Szymura, Nicholas Hardcastle, Thomas Eade, Jeremy T. Booth, Adam Briggs, Paul J. Keall

Publikováno v: Radiotherapy and Oncology. 133:S150-S151

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::762c0dbcce63f20dc48ec1060434e173
https://doi.org/10.1016/s0167-8140(19)30718-2

The first patient treatment of electromagnetic-guided real time adaptive radiotherapy using MLC tracking for lung SABR

Autor: Charlene Crasta, Ricky O'Brien, Jeremy T. Booth, Carol Haddad, Nicholas Hardcastle, Vincent Caillet, Paul J. Keall, Benjamin Harris, Thomas Eade, Kathryn Szymura

Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 121(1)

Background and purpose Real time adaptive radiotherapy that enables smaller irradiated volumes may reduce pulmonary toxicity. We report on the first patient treatment of electromagnetic-guided real time adaptive radiotherapy delivered with MLC tracki

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccbc1a157859518310787a0f4ac1d379
https://pubmed.ncbi.nlm.nih.gov/27650013

First-in-Human Clinical Experience with Real-Time Tumor Targeting Via MLC Tracking for Stereotactic Radiation Therapy of Lung Cancer

Autor: Benjamin Harris, R. O'Brien, Vincent Caillet, Dasantha Jayamanne, Kathryn Szymura, Nicholas Hardcastle, Thomas Eade, Paul J. Keall, Jeremy T. Booth, Adam Briggs

Publikováno v: International Journal of Radiation Oncology*Biology*Physics. 102:S149

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2e43438457e9b3baa69aafe58190c506
https://doi.org/10.1016/j.ijrobp.2018.06.360